Skip to main content

Axogen, Inc.

AXGN
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
SEC CIK
0000805928

In the last 90 days, Axogen, Inc. insiders filed 0 open-market purchases and 4 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Axogen, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of AXGN: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders135130−5
Shares30.7M31.6M+923.5K (+3.0%)
Value$306.8M$299.1M−$7.74M (−2.5%)

New holders (13)

Institutions that held Axogen, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to AXGN in Q1 2023
InstitutionSharesValue% of portfolio
UBS Oconnor LLC259,214$2.45M0.06%
Millrace Asset Group, Inc.188,072$1.78M2.07%
Algert Global LLC168,855$1.60M0.08%
Empire Financial Management Company, LLC31,600$298.6K0.12%
CM Wealth Advisors LLC28,759$264.0K0.05%
Susquehanna International Group, LLP21,428$202.5K0.00%
SG Americas Securities, LLC21,404$202.0K0.00%
Verition Fund Management LLC16,019$151.4K0.00%
Engineers Gate Manager LP13,312$125.8K0.01%
Zurcher Kantonalbank (Zurich Cantonalbank)12,607$119.1K0.00%
Allspring Global Investments Holdings, LLC6,170$58.3K0.00%
State of Wyoming3,708$35.0K0.01%
Fisher Asset Management, LLC181$1.71K0.00%

Sold out (18)

Institutions that held Axogen, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.